This report contains market size and forecasts of Longevity and Anti-Aging Drugs in global, including the following market information:
Global Longevity and Anti-Aging Drugs Market Revenue, 2018-2023, 2023-2032, ($ millions)
Global Longevity and Anti-Aging Drugs Market Sales, 2018-2023, 2023-2032, (K Units)
Global top five Longevity and Anti-Aging Drugs companies in 2022 (%)
The global Longevity and Anti-Aging Drugs market was valued at US$ million in 2022 and is projected to reach US$ million by 2032, at a CAGR of % during the forecast period 2023-2032.
The U.S. Market is Estimated at $ Million in 2022, While China is Forecast to Reach $ Million by 2032.
Calcium AKG Supplement Segment to Reach $ Million by 2032, with a % CAGR in next six years.
The global key manufacturers of Longevity and Anti-Aging Drugs include Vitality Pro, MoleQlar, Hansen Supplements, Supplement Place, Maxx Herb, Youth & Earth, Rejuvant LifeTabs, Renue By Science and Double Wood Supplements, etc. In 2022, the global top five players have a share approximately % in terms of revenue.
We surveyed the Longevity and Anti-Aging Drugs manufacturers, suppliers, distributors and industry experts on this industry, involving the sales, revenue, demand, price change, product type, recent development and plan, industry trends, drivers, challenges, obstacles, and potential risks.
Total Market by Segment:
Global Longevity and Anti-Aging Drugs Market, by Type, 2018-2023, 2023-2032 ($ Millions) & (K Units)
Global Longevity and Anti-Aging Drugs Market Segment Percentages, by Type, 2022 (%)
Calcium AKG Supplement
Nicotinamide Mononucleotide Supplement
Others
Global Longevity and Anti-Aging Drugs Market, by Application, 2018-2023, 2023-2032 ($ Millions) & (K Units)
Global Longevity and Anti-Aging Drugs Market Segment Percentages, by Application, 2022 (%)
Adult Male (Under 60 Years Old)
Adult Female (Under 60 Years Old)
Elderly (Above 60 Years Old)
Global Longevity and Anti-Aging Drugs Market, By Region and Country, 2018-2023, 2023-2032 ($ Millions) & (K Units)
Global Longevity and Anti-Aging Drugs Market Segment Percentages, By Region and Country, 2022 (%)
North America
US
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Nordic Countries
Benelux
Rest of Europe
Asia
China
Japan
South Korea
Southeast Asia
India
Rest of Asia
South America
Brazil
Argentina
Rest of South America
Middle East & Africa
Turkey
Israel
Saudi Arabia
UAE
Rest of Middle East & Africa
Competitor Analysis
The report also provides analysis of leading market participants including:
Key companies Longevity and Anti-Aging Drugs revenues in global market, 2018-2023 (Estimated), ($ millions)
Key companies Longevity and Anti-Aging Drugs revenues share in global market, 2022 (%)
Key companies Longevity and Anti-Aging Drugs sales in global market, 2018-2023 (Estimated), (K Units)
Key companies Longevity and Anti-Aging Drugs sales share in global market, 2022 (%)
Further, the report presents profiles of competitors in the market, key players include:
Vitality Pro
MoleQlar
Hansen Supplements
Supplement Place
Maxx Herb
Youth & Earth
Rejuvant LifeTabs
Renue By Science
Double Wood Supplements
Quicksilver Scientific
California Gold Nutrition
ProHealth Longevity
Peak Performance
Do Not Age
Nutriop
AFEGA Anti-Aging-Shop
Xi'an Angel Biotechnology Co., Ltd.
Longevity Box
Age Science
Nutravita
Aeternum
Toniiq
ProNutrition
Genex Formulas
Physicians Longevity
AlphaFit
Lovita Foods
Jarrow Formulas
Body Union
TABLE OF CONTENTS
1 Introduction to Research & Analysis Reports
1.1 Longevity and Anti-Aging Drugs Market Definition
1.2 Market Segments
1.2.1 Market by Type
1.2.2 Market by Application
1.3 Global Longevity and Anti-Aging Drugs Market Overview
1.4 Features & Benefits of This Report
1.5 Methodology & Sources of Information
1.5.1 Research Methodology
1.5.2 Research Process
1.5.3 Base Year
1.5.4 Report Assumptions & Caveats
2 Global Longevity and Anti-Aging Drugs Overall Market Size
2.1 Global Longevity and Anti-Aging Drugs Market Size: 2022 VS 2032
2.2 Global Longevity and Anti-Aging Drugs Revenue, Prospects & Forecasts: 2018-2032
2.3 Global Longevity and Anti-Aging Drugs Sales: 2018-2032
3 Company Landscape
3.1 Top Longevity and Anti-Aging Drugs Players in Global Market
3.2 Top Global Longevity and Anti-Aging Drugs Companies Ranked by Revenue
3.3 Global Longevity and Anti-Aging Drugs Revenue by Companies
3.4 Global Longevity and Anti-Aging Drugs Sales by Companies
3.5 Global Longevity and Anti-Aging Drugs Price by Manufacturer (2018-2023)
3.6 Top 3 and Top 5 Longevity and Anti-Aging Drugs Companies in Global Market, by Revenue in 2022
3.7 Global Manufacturers Longevity and Anti-Aging Drugs Product Type
3.8 Tier 1, Tier 2 and Tier 3 Longevity and Anti-Aging Drugs Players in Global Market
3.8.1 List of Global Tier 1 Longevity and Anti-Aging Drugs Companies
3.8.2 List of Global Tier 2 and Tier 3 Longevity and Anti-Aging Drugs Companies
4 Sights by Product
4.1 Overview
4.1.1 By Type - Global Longevity and Anti-Aging Drugs Market Size Markets, 2022 & 2032
4.1.2 Calcium AKG Supplement
4.1.3 Nicotinamide Mononucleotide Supplement
4.1.4 Others
4.2 By Type - Global Longevity and Anti-Aging Drugs Revenue & Forecasts
4.2.1 By Type - Global Longevity and Anti-Aging Drugs Revenue, 2018-2023
4.2.2 By Type - Global Longevity and Anti-Aging Drugs Revenue, 2023-2032
4.2.3 By Type - Global Longevity and Anti-Aging Drugs Revenue Market Share, 2018-2032
4.3 By Type - Global Longevity and Anti-Aging Drugs Sales & Forecasts
4.3.1 By Type - Global Longevity and Anti-Aging Drugs Sales, 2018-2023
4.3.2 By Type - Global Longevity and Anti-Aging Drugs Sales, 2023-2032
4.3.3 By Type - Global Longevity and Anti-Aging Drugs Sales Market Share, 2018-2032
4.4 By Type - Global Longevity and Anti-Aging Drugs Price (Manufacturers Selling Prices), 2018-2032
5 Sights By Application
5.1 Overview
5.1.1 By Application - Global Longevity and Anti-Aging Drugs Market Size, 2022 & 2032
5.1.2 Adult Male (Under 60 Years Old)
5.1.3 Adult Female (Under 60 Years Old)
5.1.4 Elderly (Above 60 Years Old)
5.2 By Application - Global Longevity and Anti-Aging Drugs Revenue & Forecasts
5.2.1 By Application - Global Longevity and Anti-Aging Drugs Revenue, 2018-2023
5.2.2 By Application - Global Longevity and Anti-Aging Drugs Revenue, 2023-2032
5.2.3 By Application - Global Longevity and Anti-Aging Drugs Revenue Market Share, 2018-2032
5.3 By Application - Global Longevity and Anti-Aging Drugs Sales & Forecasts
5.3.1 By Application - Global Longevity and Anti-Aging Drugs Sales, 2018-2023
5.3.2 By Application - Global Longevity and Anti-Aging Drugs Sales, 2023-2032
5.3.3 By Application - Global Longevity and Anti-Aging Drugs Sales Market Share, 2018-2032
5.4 By Application - Global Longevity and Anti-Aging Drugs Price (Manufacturers Selling Prices), 2018-2032
6 Sights by Region
6.1 By Region - Global Longevity and Anti-Aging Drugs Market Size, 2022 & 2032
6.2 By Region - Global Longevity and Anti-Aging Drugs Revenue & Forecasts
6.2.1 By Region - Global Longevity and Anti-Aging Drugs Revenue, 2018-2023
6.2.2 By Region - Global Longevity and Anti-Aging Drugs Revenue, 2023-2032
6.2.3 By Region - Global Longevity and Anti-Aging Drugs Revenue Market Share, 2018-2032
6.3 By Region - Global Longevity and Anti-Aging Drugs Sales & Forecasts
6.3.1 By Region - Global Longevity and Anti-Aging Drugs Sales, 2018-2023
6.3.2 By Region - Global Longevity and Anti-Aging Drugs Sales, 2023-2032
6.3.3 By Region - Global Longevity and Anti-Aging Drugs Sales Market Share, 2018-2032
6.4 North America
6.4.1 By Country - North America Longevity and Anti-Aging Drugs Revenue, 2018-2032
6.4.2 By Country - North America Longevity and Anti-Aging Drugs Sales, 2018-2032
6.4.3 US Longevity and Anti-Aging Drugs Market Size, 2018-2032
6.4.4 Canada Longevity and Anti-Aging Drugs Market Size, 2018-2032
6.4.5 Mexico Longevity and Anti-Aging Drugs Market Size, 2018-2032
6.5 Europe
6.5.1 By Country - Europe Longevity and Anti-Aging Drugs Revenue, 2018-2032
6.5.2 By Country - Europe Longevity and Anti-Aging Drugs Sales, 2018-2032
6.5.3 Germany Longevity and Anti-Aging Drugs Market Size, 2018-2032
6.5.4 France Longevity and Anti-Aging Drugs Market Size, 2018-2032
6.5.5 U.K. Longevity and Anti-Aging Drugs Market Size, 2018-2032
6.5.6 Italy Longevity and Anti-Aging Drugs Market Size, 2018-2032
6.5.7 Russia Longevity and Anti-Aging Drugs Market Size, 2018-2032
6.5.8 Nordic Countries Longevity and Anti-Aging Drugs Market Size, 2018-2032
6.5.9 Benelux Longevity and Anti-Aging Drugs Market Size, 2018-2032
6.6 Asia
6.6.1 By Region - Asia Longevity and Anti-Aging Drugs Revenue, 2018-2032
6.6.2 By Region - Asia Longevity and Anti-Aging Drugs Sales, 2018-2032
6.6.3 China Longevity and Anti-Aging Drugs Market Size, 2018-2032
6.6.4 Japan Longevity and Anti-Aging Drugs Market Size, 2018-2032
6.6.5 South Korea Longevity and Anti-Aging Drugs Market Size, 2018-2032
6.6.6 Southeast Asia Longevity and Anti-Aging Drugs Market Size, 2018-2032
6.6.7 India Longevity and Anti-Aging Drugs Market Size, 2018-2032
6.7 South America
6.7.1 By Country - South America Longevity and Anti-Aging Drugs Revenue, 2018-2032
6.7.2 By Country - South America Longevity and Anti-Aging Drugs Sales, 2018-2032
6.7.3 Brazil Longevity and Anti-Aging Drugs Market Size, 2018-2032
6.7.4 Argentina Longevity and Anti-Aging Drugs Market Size, 2018-2032
6.8 Middle East & Africa
6.8.1 By Country - Middle East & Africa Longevity and Anti-Aging Drugs Revenue, 2018-2032
6.8.2 By Country - Middle East & Africa Longevity and Anti-Aging Drugs Sales, 2018-2032
6.8.3 Turkey Longevity and Anti-Aging Drugs Market Size, 2018-2032
6.8.4 Israel Longevity and Anti-Aging Drugs Market Size, 2018-2032
6.8.5 Saudi Arabia Longevity and Anti-Aging Drugs Market Size, 2018-2032
6.8.6 UAE Longevity and Anti-Aging Drugs Market Size, 2018-2032
7 Manufacturers & Brands Profiles
7.1 Vitality Pro
7.1.1 Vitality Pro Corporate Summary
7.1.2 Vitality Pro Business Overview
7.1.3 Vitality Pro Longevity and Anti-Aging Drugs Major Product Offerings
7.1.4 Vitality Pro Longevity and Anti-Aging Drugs Sales and Revenue in Global (2018-2023)
7.1.5 Vitality Pro Key News
7.2 MoleQlar
7.2.1 MoleQlar Corporate Summary
7.2.2 MoleQlar Business Overview
7.2.3 MoleQlar Longevity and Anti-Aging Drugs Major Product Offerings
7.2.4 MoleQlar Longevity and Anti-Aging Drugs Sales and Revenue in Global (2018-2023)
7.2.5 MoleQlar Key News
7.3 Hansen Supplements
7.3.1 Hansen Supplements Corporate Summary
7.3.2 Hansen Supplements Business Overview
7.3.3 Hansen Supplements Longevity and Anti-Aging Drugs Major Product Offerings
7.3.4 Hansen Supplements Longevity and Anti-Aging Drugs Sales and Revenue in Global (2018-2023)
7.3.5 Hansen Supplements Key News
7.4 Supplement Place
7.4.1 Supplement Place Corporate Summary
7.4.2 Supplement Place Business Overview
7.4.3 Supplement Place Longevity and Anti-Aging Drugs Major Product Offerings
7.4.4 Supplement Place Longevity and Anti-Aging Drugs Sales and Revenue in Global (2018-2023)
7.4.5 Supplement Place Key News
7.5 Maxx Herb
7.5.1 Maxx Herb Corporate Summary
7.5.2 Maxx Herb Business Overview
7.5.3 Maxx Herb Longevity and Anti-Aging Drugs Major Product Offerings
7.5.4 Maxx Herb Longevity and Anti-Aging Drugs Sales and Revenue in Global (2018-2023)
7.5.5 Maxx Herb Key News
7.6 Youth & Earth
7.6.1 Youth & Earth Corporate Summary
7.6.2 Youth & Earth Business Overview
7.6.3 Youth & Earth Longevity and Anti-Aging Drugs Major Product Offerings
7.6.4 Youth & Earth Longevity and Anti-Aging Drugs Sales and Revenue in Global (2018-2023)
7.6.5 Youth & Earth Key News
7.7 Rejuvant LifeTabs
7.7.1 Rejuvant LifeTabs Corporate Summary
7.7.2 Rejuvant LifeTabs Business Overview
7.7.3 Rejuvant LifeTabs Longevity and Anti-Aging Drugs Major Product Offerings
7.7.4 Rejuvant LifeTabs Longevity and Anti-Aging Drugs Sales and Revenue in Global (2018-2023)
7.7.5 Rejuvant LifeTabs Key News
7.8 Renue By Science
7.8.1 Renue By Science Corporate Summary
7.8.2 Renue By Science Business Overview
7.8.3 Renue By Science Longevity and Anti-Aging Drugs Major Product Offerings
7.8.4 Renue By Science Longevity and Anti-Aging Drugs Sales and Revenue in Global (2018-2023)
7.8.5 Renue By Science Key News
7.9 Double Wood Supplements
7.9.1 Double Wood Supplements Corporate Summary
7.9.2 Double Wood Supplements Business Overview
7.9.3 Double Wood Supplements Longevity and Anti-Aging Drugs Major Product Offerings
7.9.4 Double Wood Supplements Longevity and Anti-Aging Drugs Sales and Revenue in Global (2018-2023)
7.9.5 Double Wood Supplements Key News
7.10 Quicksilver Scientific
7.10.1 Quicksilver Scientific Corporate Summary
7.10.2 Quicksilver Scientific Business Overview
7.10.3 Quicksilver Scientific Longevity and Anti-Aging Drugs Major Product Offerings
7.10.4 Quicksilver Scientific Longevity and Anti-Aging Drugs Sales and Revenue in Global (2018-2023)
7.10.5 Quicksilver Scientific Key News
7.11 California Gold Nutrition
7.11.1 California Gold Nutrition Corporate Summary
7.11.2 California Gold Nutrition Longevity and Anti-Aging Drugs Business Overview
7.11.3 California Gold Nutrition Longevity and Anti-Aging Drugs Major Product Offerings
7.11.4 California Gold Nutrition Longevity and Anti-Aging Drugs Sales and Revenue in Global (2018-2023)
7.11.5 California Gold Nutrition Key News
7.12 ProHealth Longevity
7.12.1 ProHealth Longevity Corporate Summary
7.12.2 ProHealth Longevity Longevity and Anti-Aging Drugs Business Overview
7.12.3 ProHealth Longevity Longevity and Anti-Aging Drugs Major Product Offerings
7.12.4 ProHealth Longevity Longevity and Anti-Aging Drugs Sales and Revenue in Global (2018-2023)
7.12.5 ProHealth Longevity Key News
7.13 Peak Performance
7.13.1 Peak Performance Corporate Summary
7.13.2 Peak Performance Longevity and Anti-Aging Drugs Business Overview
7.13.3 Peak Performance Longevity and Anti-Aging Drugs Major Product Offerings
7.13.4 Peak Performance Longevity and Anti-Aging Drugs Sales and Revenue in Global (2018-2023)
7.13.5 Peak Performance Key News
7.14 Do Not Age
7.14.1 Do Not Age Corporate Summary
7.14.2 Do Not Age Business Overview
7.14.3 Do Not Age Longevity and Anti-Aging Drugs Major Product Offerings
7.14.4 Do Not Age Longevity and Anti-Aging Drugs Sales and Revenue in Global (2018-2023)
7.14.5 Do Not Age Key News
7.15 Nutriop
7.15.1 Nutriop Corporate Summary
7.15.2 Nutriop Business Overview
7.15.3 Nutriop Longevity and Anti-Aging Drugs Major Product Offerings
7.15.4 Nutriop Longevity and Anti-Aging Drugs Sales and Revenue in Global (2018-2023)
7.15.5 Nutriop Key News
7.16 AFEGA Anti-Aging-Shop
7.16.1 AFEGA Anti-Aging-Shop Corporate Summary
7.16.2 AFEGA Anti-Aging-Shop Business Overview
7.16.3 AFEGA Anti-Aging-Shop Longevity and Anti-Aging Drugs Major Product Offerings
7.16.4 AFEGA Anti-Aging-Shop Longevity and Anti-Aging Drugs Sales and Revenue in Global (2018-2023)
7.16.5 AFEGA Anti-Aging-Shop Key News
7.17 Xi'an Angel Biotechnology Co., Ltd.
7.17.1 Xi'an Angel Biotechnology Co., Ltd. Corporate Summary
7.17.2 Xi'an Angel Biotechnology Co., Ltd. Business Overview
7.17.3 Xi'an Angel Biotechnology Co., Ltd. Longevity and Anti-Aging Drugs Major Product Offerings
7.17.4 Xi'an Angel Biotechnology Co., Ltd. Longevity and Anti-Aging Drugs Sales and Revenue in Global (2018-2023)
7.17.5 Xi'an Angel Biotechnology Co., Ltd. Key News
7.18 Longevity Box
7.18.1 Longevity Box Corporate Summary
7.18.2 Longevity Box Business Overview
7.18.3 Longevity Box Longevity and Anti-Aging Drugs Major Product Offerings
7.18.4 Longevity Box Longevity and Anti-Aging Drugs Sales and Revenue in Global (2018-2023)
7.18.5 Longevity Box Key News
7.19 Age Science
7.19.1 Age Science Corporate Summary
7.19.2 Age Science Business Overview
7.19.3 Age Science Longevity and Anti-Aging Drugs Major Product Offerings
7.19.4 Age Science Longevity and Anti-Aging Drugs Sales and Revenue in Global (2018-2023)
7.19.5 Age Science Key News
7.20 Nutravita
7.20.1 Nutravita Corporate Summary
7.20.2 Nutravita Business Overview
7.20.3 Nutravita Longevity and Anti-Aging Drugs Major Product Offerings
7.20.4 Nutravita Longevity and Anti-Aging Drugs Sales and Revenue in Global (2018-2023)
7.20.5 Nutravita Key News
7.21 Aeternum
7.21.1 Aeternum Corporate Summary
7.21.2 Aeternum Business Overview
7.21.3 Aeternum Longevity and Anti-Aging Drugs Major Product Offerings
7.21.4 Aeternum Longevity and Anti-Aging Drugs Sales and Revenue in Global (2018-2023)
7.21.5 Aeternum Key News
7.22 Toniiq
7.22.1 Toniiq Corporate Summary
7.22.2 Toniiq Business Overview
7.22.3 Toniiq Longevity and Anti-Aging Drugs Major Product Offerings
7.22.4 Toniiq Longevity and Anti-Aging Drugs Sales and Revenue in Global (2018-2023)
7.22.5 Toniiq Key News
7.23 ProNutrition
7.23.1 ProNutrition Corporate Summary
7.23.2 ProNutrition Business Overview
7.23.3 ProNutrition Longevity and Anti-Aging Drugs Major Product Offerings
7.23.4 ProNutrition Longevity and Anti-Aging Drugs Sales and Revenue in Global (2018-2023)
7.23.5 ProNutrition Key News
7.24 Genex Formulas
7.24.1 Genex Formulas Corporate Summary
7.24.2 Genex Formulas Business Overview
7.24.3 Genex Formulas Longevity and Anti-Aging Drugs Major Product Offerings
7.24.4 Genex Formulas Longevity and Anti-Aging Drugs Sales and Revenue in Global (2018-2023)
7.24.5 Genex Formulas Key News
7.25 Physicians Longevity
7.25.1 Physicians Longevity Corporate Summary
7.25.2 Physicians Longevity Business Overview
7.25.3 Physicians Longevity Longevity and Anti-Aging Drugs Major Product Offerings
7.25.4 Physicians Longevity Longevity and Anti-Aging Drugs Sales and Revenue in Global (2018-2023)
7.25.5 Physicians Longevity Key News
7.26 AlphaFit
7.26.1 AlphaFit Corporate Summary
7.26.2 AlphaFit Business Overview
7.26.3 AlphaFit Longevity and Anti-Aging Drugs Major Product Offerings
7.26.4 AlphaFit Longevity and Anti-Aging Drugs Sales and Revenue in Global (2018-2023)
7.26.5 AlphaFit Key News
7.27 Lovita Foods
7.27.1 Lovita Foods Corporate Summary
7.27.2 Lovita Foods Business Overview
7.27.3 Lovita Foods Longevity and Anti-Aging Drugs Major Product Offerings
7.27.4 Lovita Foods Longevity and Anti-Aging Drugs Sales and Revenue in Global (2018-2023)
7.27.5 Lovita Foods Key News
7.28 Jarrow Formulas
7.28.1 Jarrow Formulas Corporate Summary
7.28.2 Jarrow Formulas Business Overview
7.28.3 Jarrow Formulas Longevity and Anti-Aging Drugs Major Product Offerings
7.28.4 Jarrow Formulas Longevity and Anti-Aging Drugs Sales and Revenue in Global (2018-2023)
7.28.5 Jarrow Formulas Key News
7.29 Body Union
7.29.1 Body Union Corporate Summary
7.29.2 Body Union Business Overview
7.29.3 Body Union Longevity and Anti-Aging Drugs Major Product Offerings
7.29.4 Body Union Longevity and Anti-Aging Drugs Sales and Revenue in Global (2018-2023)
7.29.5 Body Union Key News
8 Global Longevity and Anti-Aging Drugs Production Capacity, Analysis
8.1 Global Longevity and Anti-Aging Drugs Production Capacity, 2018-2032
8.2 Longevity and Anti-Aging Drugs Production Capacity of Key Manufacturers in Global Market
8.3 Global Longevity and Anti-Aging Drugs Production by Region
9 Key Market Trends, Opportunity, Drivers and Restraints
9.1 Market Opportunities & Trends
9.2 Market Drivers
9.3 Market Restraints
10 Longevity and Anti-Aging Drugs Supply Chain Analysis
10.1 Longevity and Anti-Aging Drugs Industry Value Chain
10.2 Longevity and Anti-Aging Drugs Upstream Market
10.3 Longevity and Anti-Aging Drugs Downstream and Clients
10.4 Marketing Channels Analysis
10.4.1 Marketing Channels
10.4.2 Longevity and Anti-Aging Drugs Distributors and Sales Agents in Global
11 Conclusion
12 Appendix
12.1 Note
12.2 Examples of Clients
12.3 Disclaimer
LIST OF TABLES & FIGURES
List of Tables
Table 1. Key Players of Longevity and Anti-Aging Drugs in Global Market
Table 2. Top Longevity and Anti-Aging Drugs Players in Global Market, Ranking by Revenue (2022)
Table 3. Global Longevity and Anti-Aging Drugs Revenue by Companies, (US$, Mn), 2018-2023
Table 4. Global Longevity and Anti-Aging Drugs Revenue Share by Companies, 2018-2023
Table 5. Global Longevity and Anti-Aging Drugs Sales by Companies, (K Units), 2018-2023
Table 6. Global Longevity and Anti-Aging Drugs Sales Share by Companies, 2018-2023
Table 7. Key Manufacturers Longevity and Anti-Aging Drugs Price (2018-2023) & (US$/Unit)
Table 8. Global Manufacturers Longevity and Anti-Aging Drugs Product Type
Table 9. List of Global Tier 1 Longevity and Anti-Aging Drugs Companies, Revenue (US$, Mn) in 2022 and Market Share
Table 10. List of Global Tier 2 and Tier 3 Longevity and Anti-Aging Drugs Companies, Revenue (US$, Mn) in 2022 and Market Share
Table 11. By Type ? Global Longevity and Anti-Aging Drugs Revenue, (US$, Mn), 2022 & 2032
Table 12. By Type - Global Longevity and Anti-Aging Drugs Revenue (US$, Mn), 2018-2023
Table 13. By Type - Global Longevity and Anti-Aging Drugs Revenue (US$, Mn), 2023-2032
Table 14. By Type - Global Longevity and Anti-Aging Drugs Sales (K Units), 2018-2023
Table 15. By Type - Global Longevity and Anti-Aging Drugs Sales (K Units), 2023-2032
Table 16. By Application ? Global Longevity and Anti-Aging Drugs Revenue, (US$, Mn), 2022 & 2032
Table 17. By Application - Global Longevity and Anti-Aging Drugs Revenue (US$, Mn), 2018-2023
Table 18. By Application - Global Longevity and Anti-Aging Drugs Revenue (US$, Mn), 2023-2032
Table 19. By Application - Global Longevity and Anti-Aging Drugs Sales (K Units), 2018-2023
Table 20. By Application - Global Longevity and Anti-Aging Drugs Sales (K Units), 2023-2032
Table 21. By Region ? Global Longevity and Anti-Aging Drugs Revenue, (US$, Mn), 2022 VS 2032
Table 22. By Region - Global Longevity and Anti-Aging Drugs Revenue (US$, Mn), 2018-2023
Table 23. By Region - Global Longevity and Anti-Aging Drugs Revenue (US$, Mn), 2023-2032
Table 24. By Region - Global Longevity and Anti-Aging Drugs Sales (K Units), 2018-2023
Table 25. By Region - Global Longevity and Anti-Aging Drugs Sales (K Units), 2023-2032
Table 26. By Country - North America Longevity and Anti-Aging Drugs Revenue, (US$, Mn), 2018-2023
Table 27. By Country - North America Longevity and Anti-Aging Drugs Revenue, (US$, Mn), 2023-2032
Table 28. By Country - North America Longevity and Anti-Aging Drugs Sales, (K Units), 2018-2023
Table 29. By Country - North America Longevity and Anti-Aging Drugs Sales, (K Units), 2023-2032
Table 30. By Country - Europe Longevity and Anti-Aging Drugs Revenue, (US$, Mn), 2018-2023
Table 31. By Country - Europe Longevity and Anti-Aging Drugs Revenue, (US$, Mn), 2023-2032
Table 32. By Country - Europe Longevity and Anti-Aging Drugs Sales, (K Units), 2018-2023
Table 33. By Country - Europe Longevity and Anti-Aging Drugs Sales, (K Units), 2023-2032
Table 34. By Region - Asia Longevity and Anti-Aging Drugs Revenue, (US$, Mn), 2018-2023
Table 35. By Region - Asia Longevity and Anti-Aging Drugs Revenue, (US$, Mn), 2023-2032
Table 36. By Region - Asia Longevity and Anti-Aging Drugs Sales, (K Units), 2018-2023
Table 37. By Region - Asia Longevity and Anti-Aging Drugs Sales, (K Units), 2023-2032
Table 38. By Country - South America Longevity and Anti-Aging Drugs Revenue, (US$, Mn), 2018-2023
Table 39. By Country - South America Longevity and Anti-Aging Drugs Revenue, (US$, Mn), 2023-2032
Table 40. By Country - South America Longevity and Anti-Aging Drugs Sales, (K Units), 2018-2023
Table 41. By Country - South America Longevity and Anti-Aging Drugs Sales, (K Units), 2023-2032
Table 42. By Country - Middle East & Africa Longevity and Anti-Aging Drugs Revenue, (US$, Mn), 2018-2023
Table 43. By Country - Middle East & Africa Longevity and Anti-Aging Drugs Revenue, (US$, Mn), 2023-2032
Table 44. By Country - Middle East & Africa Longevity and Anti-Aging Drugs Sales, (K Units), 2018-2023
Table 45. By Country - Middle East & Africa Longevity and Anti-Aging Drugs Sales, (K Units), 2023-2032
Table 46. Vitality Pro Corporate Summary
Table 47. Vitality Pro Longevity and Anti-Aging Drugs Product Offerings
Table 48. Vitality Pro Longevity and Anti-Aging Drugs Sales (K Units), Revenue (US$, Mn) and Average Price (US$/Unit) (2018-2023)
Table 49. MoleQlar Corporate Summary
Table 50. MoleQlar Longevity and Anti-Aging Drugs Product Offerings
Table 51. MoleQlar Longevity and Anti-Aging Drugs Sales (K Units), Revenue (US$, Mn) and Average Price (US$/Unit) (2018-2023)
Table 52. Hansen Supplements Corporate Summary
Table 53. Hansen Supplements Longevity and Anti-Aging Drugs Product Offerings
Table 54. Hansen Supplements Longevity and Anti-Aging Drugs Sales (K Units), Revenue (US$, Mn) and Average Price (US$/Unit) (2018-2023)
Table 55. Supplement Place Corporate Summary
Table 56. Supplement Place Longevity and Anti-Aging Drugs Product Offerings
Table 57. Supplement Place Longevity and Anti-Aging Drugs Sales (K Units), Revenue (US$, Mn) and Average Price (US$/Unit) (2018-2023)
Table 58. Maxx Herb Corporate Summary
Table 59. Maxx Herb Longevity and Anti-Aging Drugs Product Offerings
Table 60. Maxx Herb Longevity and Anti-Aging Drugs Sales (K Units), Revenue (US$, Mn) and Average Price (US$/Unit) (2018-2023)
Table 61. Youth & Earth Corporate Summary
Table 62. Youth & Earth Longevity and Anti-Aging Drugs Product Offerings
Table 63. Youth & Earth Longevity and Anti-Aging Drugs Sales (K Units), Revenue (US$, Mn) and Average Price (US$/Unit) (2018-2023)
Table 64. Rejuvant LifeTabs Corporate Summary
Table 65. Rejuvant LifeTabs Longevity and Anti-Aging Drugs Product Offerings
Table 66. Rejuvant LifeTabs Longevity and Anti-Aging Drugs Sales (K Units), Revenue (US$, Mn) and Average Price (US$/Unit) (2018-2023)
Table 67. Renue By Science Corporate Summary
Table 68. Renue By Science Longevity and Anti-Aging Drugs Product Offerings
Table 69. Renue By Science Longevity and Anti-Aging Drugs Sales (K Units), Revenue (US$, Mn) and Average Price (US$/Unit) (2018-2023)
Table 70. Double Wood Supplements Corporate Summary
Table 71. Double Wood Supplements Longevity and Anti-Aging Drugs Product Offerings
Table 72. Double Wood Supplements Longevity and Anti-Aging Drugs Sales (K Units), Revenue (US$, Mn) and Average Price (US$/Unit) (2018-2023)
Table 73. Quicksilver Scientific Corporate Summary
Table 74. Quicksilver Scientific Longevity and Anti-Aging Drugs Product Offerings
Table 75. Quicksilver Scientific Longevity and Anti-Aging Drugs Sales (K Units), Revenue (US$, Mn) and Average Price (US$/Unit) (2018-2023)
Table 76. California Gold Nutrition Corporate Summary
Table 77. California Gold Nutrition Longevity and Anti-Aging Drugs Product Offerings
Table 78. California Gold Nutrition Longevity and Anti-Aging Drugs Sales (K Units), Revenue (US$, Mn) and Average Price (US$/Unit) (2018-2023)
Table 79. ProHealth Longevity Corporate Summary
Table 80. ProHealth Longevity Longevity and Anti-Aging Drugs Product Offerings
Table 81. ProHealth Longevity Longevity and Anti-Aging Drugs Sales (K Units), Revenue (US$, Mn) and Average Price (US$/Unit) (2018-2023)
Table 82. Peak Performance Corporate Summary
Table 83. Peak Performance Longevity and Anti-Aging Drugs Product Offerings
Table 84. Peak Performance Longevity and Anti-Aging Drugs Sales (K Units), Revenue (US$, Mn) and Average Price (US$/Unit) (2018-2023)
Table 85. Do Not Age Corporate Summary
Table 86. Do Not Age Longevity and Anti-Aging Drugs Product Offerings
Table 87. Do Not Age Longevity and Anti-Aging Drugs Sales (K Units), Revenue (US$, Mn) and Average Price (US$/Unit) (2018-2023)
Table 88. Nutriop Corporate Summary
Table 89. Nutriop Longevity and Anti-Aging Drugs Product Offerings
Table 90. Nutriop Longevity and Anti-Aging Drugs Sales (K Units), Revenue (US$, Mn) and Average Price (US$/Unit) (2018-2023)
Table 91. AFEGA Anti-Aging-Shop Corporate Summary
Table 92. AFEGA Anti-Aging-Shop Longevity and Anti-Aging Drugs Product Offerings
Table 93. AFEGA Anti-Aging-Shop Longevity and Anti-Aging Drugs Sales (K Units), Revenue (US$, Mn) and Average Price (US$/Unit) (2018-2023)
Table 94. Xi'an Angel Biotechnology Co., Ltd. Corporate Summary
Table 95. Xi'an Angel Biotechnology Co., Ltd. Longevity and Anti-Aging Drugs Product Offerings
Table 96. Xi'an Angel Biotechnology Co., Ltd. Longevity and Anti-Aging Drugs Sales (K Units), Revenue (US$, Mn) and Average Price (US$/Unit) (2018-2023)
Table 97. Longevity Box Corporate Summary
Table 98. Longevity Box Longevity and Anti-Aging Drugs Product Offerings
Table 99. Longevity Box Longevity and Anti-Aging Drugs Sales (K Units), Revenue (US$, Mn) and Average Price (US$/Unit) (2018-2023)
Table 100. Age Science Corporate Summary
Table 101. Age Science Longevity and Anti-Aging Drugs Product Offerings
Table 102. Age Science Longevity and Anti-Aging Drugs Sales (K Units), Revenue (US$, Mn) and Average Price (US$/Unit) (2018-2023)
Table 103. Nutravita Corporate Summary
Table 104. Nutravita Longevity and Anti-Aging Drugs Product Offerings
Table 105. Nutravita Longevity and Anti-Aging Drugs Sales (K Units), Revenue (US$, Mn) and Average Price (US$/Unit) (2018-2023)
Table 106. Aeternum Corporate Summary
Table 107. Aeternum Longevity and Anti-Aging Drugs Product Offerings
Table 108. Aeternum Longevity and Anti-Aging Drugs Sales (K Units), Revenue (US$, Mn) and Average Price (US$/Unit) (2018-2023)
Table 109. Toniiq Corporate Summary
Table 110. Toniiq Longevity and Anti-Aging Drugs Product Offerings
Table 111. Toniiq Longevity and Anti-Aging Drugs Sales (K Units), Revenue (US$, Mn) and Average Price (US$/Unit) (2018-2023)
Table 112. ProNutrition Corporate Summary
Table 113. ProNutrition Longevity and Anti-Aging Drugs Product Offerings
Table 114. ProNutrition Longevity and Anti-Aging Drugs Sales (K Units), Revenue (US$, Mn) and Average Price (US$/Unit) (2018-2023)
Table 115. Genex Formulas Corporate Summary
Table 116. Genex Formulas Longevity and Anti-Aging Drugs Product Offerings
Table 117. Genex Formulas Longevity and Anti-Aging Drugs Sales (K Units), Revenue (US$, Mn) and Average Price (US$/Unit) (2018-2023)
Table 118. Physicians Longevity Corporate Summary
Table 119. Physicians Longevity Longevity and Anti-Aging Drugs Product Offerings
Table 120. Physicians Longevity Longevity and Anti-Aging Drugs Sales (K Units), Revenue (US$, Mn) and Average Price (US$/Unit) (2018-2023)
Table 121. AlphaFit Corporate Summary
Table 122. AlphaFit Longevity and Anti-Aging Drugs Product Offerings
Table 123. AlphaFit Longevity and Anti-Aging Drugs Sales (K Units), Revenue (US$, Mn) and Average Price (US$/Unit) (2018-2023)
Table 124. Lovita Foods Corporate Summary
Table 125. Lovita Foods Longevity and Anti-Aging Drugs Product Offerings
Table 126. Lovita Foods Longevity and Anti-Aging Drugs Sales (K Units), Revenue (US$, Mn) and Average Price (US$/Unit) (2018-2023)
Table 127. Jarrow Formulas Corporate Summary
Table 128. Jarrow Formulas Longevity and Anti-Aging Drugs Product Offerings
Table 129. Jarrow Formulas Longevity and Anti-Aging Drugs Sales (K Units), Revenue (US$, Mn) and Average Price (US$/Unit) (2018-2023)
Table 130. Body Union Corporate Summary
Table 131. Body Union Longevity and Anti-Aging Drugs Product Offerings
Table 132. Body Union Longevity and Anti-Aging Drugs Sales (K Units), Revenue (US$, Mn) and Average Price (US$/Unit) (2018-2023)
Table 133. Longevity and Anti-Aging Drugs Production Capacity (K Units) of Key Manufacturers in Global Market, 2020-2023 (K Units)
Table 134. Global Longevity and Anti-Aging Drugs Capacity Market Share of Key Manufacturers, 2020-2023
Table 135. Global Longevity and Anti-Aging Drugs Production by Region, 2018-2023 (K Units)
Table 136. Global Longevity and Anti-Aging Drugs Production by Region, 2023-2032 (K Units)
Table 137. Longevity and Anti-Aging Drugs Market Opportunities & Trends in Global Market
Table 138. Longevity and Anti-Aging Drugs Market Drivers in Global Market
Table 139. Longevity and Anti-Aging Drugs Market Restraints in Global Market
Table 140. Longevity and Anti-Aging Drugs Raw Materials
Table 141. Longevity and Anti-Aging Drugs Raw Materials Suppliers in Global Market
Table 142. Typical Longevity and Anti-Aging Drugs Downstream
Table 143. Longevity and Anti-Aging Drugs Downstream Clients in Global Market
Table 144. Longevity and Anti-Aging Drugs Distributors and Sales Agents in Global Market
List of Figures
Figure 1. Longevity and Anti-Aging Drugs Segment by Type
Figure 2. Longevity and Anti-Aging Drugs Segment by Application
Figure 3. Global Longevity and Anti-Aging Drugs Market Overview: 2022
Figure 4. Key Caveats
Figure 5. Global Longevity and Anti-Aging Drugs Market Size: 2022 VS 2032 (US$, Mn)
Figure 6. Global Longevity and Anti-Aging Drugs Revenue, 2018-2032 (US$, Mn)
Figure 7. Longevity and Anti-Aging Drugs Sales in Global Market: 2018-2032 (K Units)
Figure 8. The Top 3 and 5 Players Market Share by Longevity and Anti-Aging Drugs Revenue in 2022
Figure 9. By Type - Global Longevity and Anti-Aging Drugs Sales Market Share, 2018-2032
Figure 10. By Type - Global Longevity and Anti-Aging Drugs Revenue Market Share, 2018-2032
Figure 11. By Type - Global Longevity and Anti-Aging Drugs Price (US$/Unit), 2018-2032
Figure 12. By Application - Global Longevity and Anti-Aging Drugs Sales Market Share, 2018-2032
Figure 13. By Application - Global Longevity and Anti-Aging Drugs Revenue Market Share, 2018-2032
Figure 14. By Application - Global Longevity and Anti-Aging Drugs Price (US$/Unit), 2018-2032
Figure 15. By Region - Global Longevity and Anti-Aging Drugs Sales Market Share, 2018-2032
Figure 16. By Region - Global Longevity and Anti-Aging Drugs Revenue Market Share, 2018-2032
Figure 17. By Country - North America Longevity and Anti-Aging Drugs Revenue Market Share, 2018-2032
Figure 18. By Country - North America Longevity and Anti-Aging Drugs Sales Market Share, 2018-2032
Figure 19. US Longevity and Anti-Aging Drugs Revenue, (US$, Mn), 2018-2032
Figure 20. Canada Longevity and Anti-Aging Drugs Revenue, (US$, Mn), 2018-2032
Figure 21. Mexico Longevity and Anti-Aging Drugs Revenue, (US$, Mn), 2018-2032
Figure 22. By Country - Europe Longevity and Anti-Aging Drugs Revenue Market Share, 2018-2032
Figure 23. By Country - Europe Longevity and Anti-Aging Drugs Sales Market Share, 2018-2032
Figure 24. Germany Longevity and Anti-Aging Drugs Revenue, (US$, Mn), 2018-2032
Figure 25. France Longevity and Anti-Aging Drugs Revenue, (US$, Mn), 2018-2032
Figure 26. U.K. Longevity and Anti-Aging Drugs Revenue, (US$, Mn), 2018-2032
Figure 27. Italy Longevity and Anti-Aging Drugs Revenue, (US$, Mn), 2018-2032
Figure 28. Russia Longevity and Anti-Aging Drugs Revenue, (US$, Mn), 2018-2032
Figure 29. Nordic Countries Longevity and Anti-Aging Drugs Revenue, (US$, Mn), 2018-2032
Figure 30. Benelux Longevity and Anti-Aging Drugs Revenue, (US$, Mn), 2018-2032
Figure 31. By Region - Asia Longevity and Anti-Aging Drugs Revenue Market Share, 2018-2032
Figure 32. By Region - Asia Longevity and Anti-Aging Drugs Sales Market Share, 2018-2032
Figure 33. China Longevity and Anti-Aging Drugs Revenue, (US$, Mn), 2018-2032
Figure 34. Japan Longevity and Anti-Aging Drugs Revenue, (US$, Mn), 2018-2032
Figure 35. South Korea Longevity and Anti-Aging Drugs Revenue, (US$, Mn), 2018-2032
Figure 36. Southeast Asia Longevity and Anti-Aging Drugs Revenue, (US$, Mn), 2018-2032
Figure 37. India Longevity and Anti-Aging Drugs Revenue, (US$, Mn), 2018-2032
Figure 38. By Country - South America Longevity and Anti-Aging Drugs Revenue Market Share, 2018-2032
Figure 39. By Country - South America Longevity and Anti-Aging Drugs Sales Market Share, 2018-2032
Figure 40. Brazil Longevity and Anti-Aging Drugs Revenue, (US$, Mn), 2018-2032
Figure 41. Argentina Longevity and Anti-Aging Drugs Revenue, (US$, Mn), 2018-2032
Figure 42. By Country - Middle East & Africa Longevity and Anti-Aging Drugs Revenue Market Share, 2018-2032
Figure 43. By Country - Middle East & Africa Longevity and Anti-Aging Drugs Sales Market Share, 2018-2032
Figure 44. Turkey Longevity and Anti-Aging Drugs Revenue, (US$, Mn), 2018-2032
Figure 45. Israel Longevity and Anti-Aging Drugs Revenue, (US$, Mn), 2018-2032
Figure 46. Saudi Arabia Longevity and Anti-Aging Drugs Revenue, (US$, Mn), 2018-2032
Figure 47. UAE Longevity and Anti-Aging Drugs Revenue, (US$, Mn), 2018-2032
Figure 48. Global Longevity and Anti-Aging Drugs Production Capacity (K Units), 2018-2032
Figure 49. The Percentage of Production Longevity and Anti-Aging Drugs by Region, 2022 VS 2032
Figure 50. Longevity and Anti-Aging Drugs Industry Value Chain
Figure 51. Marketing Channels
